|
It was reported a total of four performer introducers from this same lot leaked from the diaphragm on separate occasions.Reportedly, three events of leaking occurred during "arteriovenous fistula and or graft" thrombectomies.In these three events a 0.035 j-wire was in place inside the complaint device at the time.Estimated blood loss was described as "minimal".No medical intervention was required.The procedure was completed using a different device.Patient's outcome was described as "fine".The fourth leaking event occurred during testing of the performer introducer prior to patient contact.This report is for one performer introducer which leaked during the procedure.Please see the following medwatch reports for the three other events: 1820334-2018-03769, 1820334-2018-03771, 1820334-2018-03772.
|
|
A review of the dimensional verification functional test, complaint history, device history, manufacturing instructions, review of trends, visual inspection, and quality control were conducted during the investigation.The customer returned one rycfw-7.0-35-6-rb-cw with the dilator partially inserted into the device.There is no visible damage to the introducer or dilator.The device has biological matter throughout.The tubing was occluded with hemostats and water was injected into the side arm to test for leakage.The device leaked around the silicone disc.There is no glue on the top of fitting, visible glue on the threads, and no glue in cap.Additionally, a document-based investigation evaluation was performed.The proper procedures are in place to identify and prevent this failure mode prior to device distribution.The identified risk controls include manufacturing quality control checks and process validation.A review of the device history record for lot 9118563 did not show any related nonconformances and associated complaints for this lot.There is no evidence of nonconforming material in the field.Appropriate measures are being conducted to address this failure mode.The appropriate personnel have been notified.Per the quality engineering risk assessment, no further action is required.Cook will continue to monitor for similar complaints.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
|